Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan

We outlined five studies regarding the quality of the review by committees based on the Act on the Safety of Regenerative Medicine. The findings raise serious concerns about the independence, integrity, and quality of reviews of therapeutic plans by these committees with inappropriately close relati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Stem cell reports 2023-03, Vol.18 (3), p.613-617
Hauptverfasser: Ikka, Tsunakuni, Fujita, Misao, Hatta, Taichi, Isobe, Tetsu, Konomi, Kenji, Onishi, Tatsuo, Sanada, Shoji, Sato, Yuichiro, Tashiro, Shimon, Tobita, Morikuni
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 617
container_issue 3
container_start_page 613
container_title Stem cell reports
container_volume 18
creator Ikka, Tsunakuni
Fujita, Misao
Hatta, Taichi
Isobe, Tetsu
Konomi, Kenji
Onishi, Tatsuo
Sanada, Shoji
Sato, Yuichiro
Tashiro, Shimon
Tobita, Morikuni
description We outlined five studies regarding the quality of the review by committees based on the Act on the Safety of Regenerative Medicine. The findings raise serious concerns about the independence, integrity, and quality of reviews of therapeutic plans by these committees with inappropriately close relationships to medical institutions and companies. [Display omitted]
doi_str_mv 10.1016/j.stemcr.2023.01.013
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10031296</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2213671123000164</els_id><sourcerecordid>2780076050</sourcerecordid><originalsourceid>FETCH-LOGICAL-c574t-2f30fd5b94f2ed0f39b9227032835fb810a8abfb44db4a1b0a3ce0c5fa75194a3</originalsourceid><addsrcrecordid>eNp9UUtrXCEUltLQhCT_oBSX3cz0qPe5aQlJnyQE-liLeo8Th3t1ot4ps-h_r9NJQ7qpHPCA3-N4PkJeMlgyYM2b9TJlnExccuBiCayUeEZOOGdi0bSMPX_SH5PzlNZQTt8zXrEX5Fg0HW_7tj0hv66ctc7MY3aYqPMUfZqj8ysacevwJ72f1ejyjm4w2hAnHKjeUROmyeWMhTL7ASPNd0gvTKbB_2m_KYuFEyz9iiv0GFV2W6Q3ODjjPO59vqiN8mfkyKox4fnDfUp-fHj__fLT4vr24-fLi-uFqdsqL7gVYIda95XlOIAVve45b0HwTtRWdwxUp7TVVTXoSjENShgEU1vV1qyvlDgl7w66m1mXLxj0OapRbqKbVNzJoJz898W7O7kKW8kABON9UxRePyjEcD9jynJyyeA4Ko9hTpK3HUDbQA0FWh2gJoaUItpHHwZyn55cy0N6cp-eBFZKFNqrpzM-kv5mVQBvDwAsmyrZRJmMQ2_KUiOaLIfg_u_wG4VYsHI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2780076050</pqid></control><display><type>article</type><title>Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Ikka, Tsunakuni ; Fujita, Misao ; Hatta, Taichi ; Isobe, Tetsu ; Konomi, Kenji ; Onishi, Tatsuo ; Sanada, Shoji ; Sato, Yuichiro ; Tashiro, Shimon ; Tobita, Morikuni</creator><creatorcontrib>Ikka, Tsunakuni ; Fujita, Misao ; Hatta, Taichi ; Isobe, Tetsu ; Konomi, Kenji ; Onishi, Tatsuo ; Sanada, Shoji ; Sato, Yuichiro ; Tashiro, Shimon ; Tobita, Morikuni</creatorcontrib><description>We outlined five studies regarding the quality of the review by committees based on the Act on the Safety of Regenerative Medicine. The findings raise serious concerns about the independence, integrity, and quality of reviews of therapeutic plans by these committees with inappropriately close relationships to medical institutions and companies. [Display omitted]</description><identifier>ISSN: 2213-6711</identifier><identifier>EISSN: 2213-6711</identifier><identifier>DOI: 10.1016/j.stemcr.2023.01.013</identifier><identifier>PMID: 36827977</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Forum ; Japan ; Regenerative Medicine</subject><ispartof>Stem cell reports, 2023-03, Vol.18 (3), p.613-617</ispartof><rights>2023 The Author(s)</rights><rights>Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</rights><rights>2023 The Author(s) 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c574t-2f30fd5b94f2ed0f39b9227032835fb810a8abfb44db4a1b0a3ce0c5fa75194a3</citedby><cites>FETCH-LOGICAL-c574t-2f30fd5b94f2ed0f39b9227032835fb810a8abfb44db4a1b0a3ce0c5fa75194a3</cites><orcidid>0000-0002-5627-1411 ; 0000-0001-7919-5362</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031296/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031296/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36827977$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ikka, Tsunakuni</creatorcontrib><creatorcontrib>Fujita, Misao</creatorcontrib><creatorcontrib>Hatta, Taichi</creatorcontrib><creatorcontrib>Isobe, Tetsu</creatorcontrib><creatorcontrib>Konomi, Kenji</creatorcontrib><creatorcontrib>Onishi, Tatsuo</creatorcontrib><creatorcontrib>Sanada, Shoji</creatorcontrib><creatorcontrib>Sato, Yuichiro</creatorcontrib><creatorcontrib>Tashiro, Shimon</creatorcontrib><creatorcontrib>Tobita, Morikuni</creatorcontrib><title>Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan</title><title>Stem cell reports</title><addtitle>Stem Cell Reports</addtitle><description>We outlined five studies regarding the quality of the review by committees based on the Act on the Safety of Regenerative Medicine. The findings raise serious concerns about the independence, integrity, and quality of reviews of therapeutic plans by these committees with inappropriately close relationships to medical institutions and companies. [Display omitted]</description><subject>Forum</subject><subject>Japan</subject><subject>Regenerative Medicine</subject><issn>2213-6711</issn><issn>2213-6711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UUtrXCEUltLQhCT_oBSX3cz0qPe5aQlJnyQE-liLeo8Th3t1ot4ps-h_r9NJQ7qpHPCA3-N4PkJeMlgyYM2b9TJlnExccuBiCayUeEZOOGdi0bSMPX_SH5PzlNZQTt8zXrEX5Fg0HW_7tj0hv66ctc7MY3aYqPMUfZqj8ysacevwJ72f1ejyjm4w2hAnHKjeUROmyeWMhTL7ASPNd0gvTKbB_2m_KYuFEyz9iiv0GFV2W6Q3ODjjPO59vqiN8mfkyKox4fnDfUp-fHj__fLT4vr24-fLi-uFqdsqL7gVYIda95XlOIAVve45b0HwTtRWdwxUp7TVVTXoSjENShgEU1vV1qyvlDgl7w66m1mXLxj0OapRbqKbVNzJoJz898W7O7kKW8kABON9UxRePyjEcD9jynJyyeA4Ko9hTpK3HUDbQA0FWh2gJoaUItpHHwZyn55cy0N6cp-eBFZKFNqrpzM-kv5mVQBvDwAsmyrZRJmMQ2_KUiOaLIfg_u_wG4VYsHI</recordid><startdate>20230314</startdate><enddate>20230314</enddate><creator>Ikka, Tsunakuni</creator><creator>Fujita, Misao</creator><creator>Hatta, Taichi</creator><creator>Isobe, Tetsu</creator><creator>Konomi, Kenji</creator><creator>Onishi, Tatsuo</creator><creator>Sanada, Shoji</creator><creator>Sato, Yuichiro</creator><creator>Tashiro, Shimon</creator><creator>Tobita, Morikuni</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5627-1411</orcidid><orcidid>https://orcid.org/0000-0001-7919-5362</orcidid></search><sort><creationdate>20230314</creationdate><title>Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan</title><author>Ikka, Tsunakuni ; Fujita, Misao ; Hatta, Taichi ; Isobe, Tetsu ; Konomi, Kenji ; Onishi, Tatsuo ; Sanada, Shoji ; Sato, Yuichiro ; Tashiro, Shimon ; Tobita, Morikuni</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c574t-2f30fd5b94f2ed0f39b9227032835fb810a8abfb44db4a1b0a3ce0c5fa75194a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Forum</topic><topic>Japan</topic><topic>Regenerative Medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ikka, Tsunakuni</creatorcontrib><creatorcontrib>Fujita, Misao</creatorcontrib><creatorcontrib>Hatta, Taichi</creatorcontrib><creatorcontrib>Isobe, Tetsu</creatorcontrib><creatorcontrib>Konomi, Kenji</creatorcontrib><creatorcontrib>Onishi, Tatsuo</creatorcontrib><creatorcontrib>Sanada, Shoji</creatorcontrib><creatorcontrib>Sato, Yuichiro</creatorcontrib><creatorcontrib>Tashiro, Shimon</creatorcontrib><creatorcontrib>Tobita, Morikuni</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Stem cell reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ikka, Tsunakuni</au><au>Fujita, Misao</au><au>Hatta, Taichi</au><au>Isobe, Tetsu</au><au>Konomi, Kenji</au><au>Onishi, Tatsuo</au><au>Sanada, Shoji</au><au>Sato, Yuichiro</au><au>Tashiro, Shimon</au><au>Tobita, Morikuni</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan</atitle><jtitle>Stem cell reports</jtitle><addtitle>Stem Cell Reports</addtitle><date>2023-03-14</date><risdate>2023</risdate><volume>18</volume><issue>3</issue><spage>613</spage><epage>617</epage><pages>613-617</pages><issn>2213-6711</issn><eissn>2213-6711</eissn><abstract>We outlined five studies regarding the quality of the review by committees based on the Act on the Safety of Regenerative Medicine. The findings raise serious concerns about the independence, integrity, and quality of reviews of therapeutic plans by these committees with inappropriately close relationships to medical institutions and companies. [Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36827977</pmid><doi>10.1016/j.stemcr.2023.01.013</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-5627-1411</orcidid><orcidid>https://orcid.org/0000-0001-7919-5362</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2213-6711
ispartof Stem cell reports, 2023-03, Vol.18 (3), p.613-617
issn 2213-6711
2213-6711
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10031296
source MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Forum
Japan
Regenerative Medicine
title Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T18%3A45%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Difficulties%20in%20ensuring%20review%20quality%20performed%20by%20committees%20under%20the%20Act%20on%20the%20Safety%20of%20Regenerative%20Medicine%20in%20Japan&rft.jtitle=Stem%20cell%20reports&rft.au=Ikka,%20Tsunakuni&rft.date=2023-03-14&rft.volume=18&rft.issue=3&rft.spage=613&rft.epage=617&rft.pages=613-617&rft.issn=2213-6711&rft.eissn=2213-6711&rft_id=info:doi/10.1016/j.stemcr.2023.01.013&rft_dat=%3Cproquest_pubme%3E2780076050%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2780076050&rft_id=info:pmid/36827977&rft_els_id=S2213671123000164&rfr_iscdi=true